Network abnormalities and interneuron dysfunction in Alzheimer disease

[1]  Heidi E Kirsch,et al.  Incidence and impact of subclinical epileptiform activity in Alzheimer's disease , 2016, Annals of neurology.

[2]  J. Pariente,et al.  Seizures in dominantly inherited Alzheimer disease , 2016, Neurology.

[3]  Mattias P. Karlsson,et al.  Apolipoprotein E4 Causes Age-Dependent Disruption of Slow Gamma Oscillations during Hippocampal Sharp-Wave Ripples , 2016, Neuron.

[4]  S. Maeda,et al.  Expression of A152T human tau causes age‐dependent neuronal dysfunction and loss in transgenic mice , 2016, EMBO reports.

[5]  A. Szűcs,et al.  Epileptic Seizures in Alzheimer Disease: A Review , 2016, Alzheimer disease and associated disorders.

[6]  J. Noebels,et al.  Shift in interictal relative gamma power as a novel biomarker for drug response in two mouse models of absence epilepsy , 2016, Epilepsia.

[7]  L. Mucke,et al.  DNA repair factor BRCA1 depletion occurs in Alzheimer brains and impairs cognitive function in mice , 2015, Nature Communications.

[8]  Lukas Kunz,et al.  Reduced grid-cell–like representations in adults at genetic risk for Alzheimer’s disease , 2015, Science.

[9]  Meaghan Morris,et al.  Network dysfunction in α‐synuclein transgenic mice and human Lewy body dementia , 2015, Annals of clinical and translational neurology.

[10]  Hans Förstl,et al.  Rescue of long-range circuit dysfunction in Alzheimer's disease models , 2015, Nature Neuroscience.

[11]  D. Walsh,et al.  Anti-Aβ antibodies incapable of reducing cerebral Aβ oligomers fail to attenuate spatial reference memory deficits in J20 mice , 2015, Neurobiology of Disease.

[12]  Jochen Herms,et al.  η-Secretase processing of APP inhibits neuronal activity in the hippocampus , 2015, Nature.

[13]  K. Zahs,et al.  Quaternary Structure Defines a Large Class of Amyloid-β Oligomers Neutralized by Sequestration. , 2015, Cell reports.

[14]  Burkhard Becher,et al.  Immune attack: the role of inflammation in Alzheimer disease , 2015, Nature Reviews Neuroscience.

[15]  Lief E. Fenno,et al.  Chronic optogenetic activation augments Aβ pathology in a mouse model of Alzheimer disease , 2022 .

[16]  S. Strittmatter,et al.  Brivaracetam, but not ethosuximide, reverses memory impairments in an Alzheimer’s disease mouse model , 2015, Alzheimer's Research & Therapy.

[17]  D. Holtzman,et al.  Three dimensions of the amyloid hypothesis: time, space and 'wingmen' , 2015, Nature Neuroscience.

[18]  N. Axmacher,et al.  Neuronal Network Oscillations in Neurodegenerative Diseases , 2015, NeuroMolecular Medicine.

[19]  A. Papazoglou,et al.  Altered Theta Oscillations and Aberrant Cortical Excitatory Activity in the 5XFAD Model of Alzheimer's Disease , 2015, Neural plasticity.

[20]  Claire Rampon,et al.  Early Onset of Hypersynchronous Network Activity and Expression of a Marker of Chronic Seizures in the Tg2576 Mouse Model of Alzheimer’s Disease , 2015, PloS one.

[21]  R. J. Kelleher,et al.  Presenilin-1 Knockin Mice Reveal Loss-of-Function Mechanism for Familial Alzheimer’s Disease , 2015, Neuron.

[22]  Caroline L. Speck,et al.  Response of the medial temporal lobe network in amnestic mild cognitive impairment to therapeutic intervention assessed by fMRI and memory task performance , 2015, NeuroImage: Clinical.

[23]  Weikun Guo,et al.  Astrocytic adenosine receptor A2A and Gs-coupled signaling regulate memory , 2014, Nature Neuroscience.

[24]  J. Hablitz,et al.  Functional changes in glutamate transporters and astrocyte biophysical properties in a rodent model of focal cortical dysplasia , 2014, Front. Cell. Neurosci..

[25]  Susanne Schoch,et al.  Dendritic Structural Degeneration Is Functionally Linked to Cellular Hyperexcitability in a Mouse Model of Alzheimer’s Disease , 2014, Neuron.

[26]  J. Gabrieli,et al.  Medial temporal lobe default mode functioning and hippocampal structure as vulnerability indicators for schizophrenia: A MRI study of non-psychotic adolescent first-degree relatives , 2014, Schizophrenia Research.

[27]  A. Ittner,et al.  p38 MAP kinase-mediated NMDA receptor-dependent suppression of hippocampal hypersynchronicity in a mouse model of Alzheimer’s disease , 2014, Acta neuropathologica communications.

[28]  A. Gillespie,et al.  Apolipoprotein E4 Produced in GABAergic Interneurons Causes Learning and Memory Deficits in Mice , 2014, Journal of Neuroscience.

[29]  M. Zilberter,et al.  Amyloid-β-Induced Action Potential Desynchronization and Degradation of Hippocampal Gamma Oscillations Is Prevented by Interference with Peptide Conformation Change and Aggregation , 2014, The Journal of Neuroscience.

[30]  Arturo Alvarez-Buylla,et al.  Inhibitory Interneuron Progenitor Transplantation Restores Normal Learning and Memory in ApoE4 Knock-In Mice without or with Aβ Accumulation , 2014, The Journal of Neuroscience.

[31]  N. Krogan,et al.  Critical Role of Acetylation in Tau-Mediated Neurodegeneration and Cognitive Deficits , 2015, Nature Medicine.

[32]  A. Goate,et al.  Alzheimer’s Disease Genetics: From the Bench to the Clinic , 2014, Neuron.

[33]  L. Tsai,et al.  DNA Damage and Its Links to Neurodegeneration , 2014, Neuron.

[34]  T. Losey,et al.  Seizures and dementia in the elderly: Nationwide Inpatient Sample 1999–2008 , 2014, Epilepsy & Behavior.

[35]  S. Tonegawa,et al.  Successful Execution of Working Memory Linked to Synchronized High-Frequency Gamma Oscillations , 2014, Cell.

[36]  Martin J. Schmidt,et al.  Modulation of behavioral networks by selective interneuronal inactivation , 2014, Molecular Psychiatry.

[37]  S. Itohara,et al.  Single App knock-in mouse models of Alzheimer's disease , 2014, Nature Neuroscience.

[38]  M. Stryker,et al.  Interneurons from Embryonic Development to Cell-Based Therapy , 2014, Science.

[39]  S. Pimplikar.  Neuroinflammation in Alzheimer’s Disease: from Pathogenesis to a Therapeutic Target , 2014, Journal of Clinical Immunology.

[40]  K. Specht,et al.  Default mode network alterations during language task performance in children with benign epilepsy with centrotemporal spikes (BECTS) , 2014, Epilepsy & Behavior.

[41]  M. Stryker,et al.  A Cortical Circuit for Gain Control by Behavioral State , 2014, Cell.

[42]  T. Golde,et al.  Genetic Suppression of Transgenic APP Rescues Hypersynchronous Network Activity in a Mouse Model of Alzeimer's Disease , 2014, The Journal of Neuroscience.

[43]  Richard E. Boyatzis,et al.  Antagonistic neural networks underlying differentiated leadership roles , 2014, Front. Hum. Neurosci..

[44]  J. Bastlund,et al.  Therapeutic potential of Na(V)1.1 activators. , 2014, Trends in pharmacological sciences.

[45]  G. Fishell,et al.  Interneuron cell types are fit to function , 2014, Nature.

[46]  Davide Quaranta,et al.  Neuropsychological predictors of conversion from mild cognitive impairment to Alzheimer's disease. , 2013, Journal of Alzheimer's disease : JAD.

[47]  C. D'Avanzo,et al.  The E280A Presenilin Mutation Reduces Voltage-Gated Sodium Channel Levels in Neuronal Cells , 2013, Neurodegenerative Diseases.

[48]  Wolf Singer,et al.  Evidence for dysregulated high-frequency oscillations during sensory processing in medication-naïve, first episode schizophrenia , 2013, Schizophrenia Research.

[49]  P. Somogyi,et al.  Network state-dependent inhibition of identified hippocampal CA3 axo-axonic cells in vivo , 2013, Nature Neuroscience.

[50]  Daniel J. R. Christensen,et al.  Sleep Drives Metabolite Clearance from the Adult Brain , 2013, Science.

[51]  J. Serratosa,et al.  Hyperexcitability and epileptic seizures in a model of frontotemporal dementia , 2013, Neurobiology of Disease.

[52]  Caleb Kemere,et al.  Rapid and Continuous Modulation of Hippocampal Network State during Exploration of New Places , 2013, PloS one.

[53]  Heidi E Kirsch,et al.  Seizures and epileptiform activity in the early stages of Alzheimer disease. , 2013, JAMA neurology.

[54]  D. Holtzman,et al.  Antisense Reduction of Tau in Adult Mice Protects against Seizures , 2013, The Journal of Neuroscience.

[55]  K. Zahs,et al.  β-Amyloid oligomers in aging and Alzheimer’s disease , 2013, Front. Aging Neurosci..

[56]  Jean Gotman,et al.  Epileptic Discharges Affect the Default Mode Network – fMRI and Intracerebral EEG Evidence , 2013, PloS one.

[57]  Matt Stead,et al.  Network oscillations modulate interictal epileptiform spike rate during human memory. , 2013, Brain : a journal of neurology.

[58]  Jesse Jackson,et al.  Alterations in hippocampal network oscillations and theta–gamma coupling arise before Aβ overproduction in a mouse model of Alzheimer's disease , 2013, The European journal of neuroscience.

[59]  B. Hangya,et al.  Distinct behavioural and network correlates of two interneuron types in prefrontal cortex , 2013, Nature.

[60]  H. Tanila,et al.  Increased cortical and thalamic excitability in freely moving APPswe/PS1dE9 mice modeling epileptic activity associated with Alzheimer's disease. , 2013, Cerebral cortex.

[61]  David A Bennett,et al.  Brain amyloid-β oligomers in ageing and Alzheimer's disease. , 2013, Brain : a journal of neurology.

[62]  J. Rubenstein,et al.  GABA progenitors grafted into the adult epileptic brain control seizures and abnormal behavior , 2013, Nature Neuroscience.

[63]  M. Pangalos,et al.  Sodium Channel Cleavage Is Associated with Aberrant Neuronal Activity and Cognitive Deficits in a Mouse Model of Alzheimer's Disease , 2013, The Journal of Neuroscience.

[64]  I. Slutsky,et al.  Spike bursts increase amyloid-β 40/42 ratio by inducing a presenilin-1 conformational change , 2013, Nature Neuroscience.

[65]  M. Schuerch,et al.  Seizures in patients with Alzheimer’s disease or vascular dementia: A population‐based nested case–control analysis , 2013, Epilepsia.

[66]  Anatol C. Kreitzer,et al.  Physiological Brain Activity Causes DNA Double Strand Breaks in Neurons — Exacerbation by Amyloid-β , 2013, Nature Neuroscience.

[67]  M. Kahana,et al.  Synchronous and Asynchronous Theta and Gamma Activity during Episodic Memory Formation , 2013, The Journal of Neuroscience.

[68]  R. Mahley,et al.  Apolipoprotein E Sets the Stage: Response to Injury Triggers Neuropathology , 2012, Neuron.

[69]  Kewei Chen,et al.  Brain imaging and fluid biomarker analysis in young adults at genetic risk for autosomal dominant Alzheimer's disease in the presenilin 1 E280A kindred: a case-control study , 2012, The Lancet Neurology.

[70]  Michael W. Cole,et al.  The role of default network deactivation in cognition and disease , 2012, Trends in Cognitive Sciences.

[71]  J. Delgado-García,et al.  Accelerated aging of the GABAergic septohippocampal pathway and decreased hippocampal rhythms in a mouse model of Alzheimer's disease , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[72]  P. Solomon,et al.  New Criteria for Alzheimer Disease and Mild Cognitive Impairment: Implications for the Practicing Clinician , 2012, The neurologist.

[73]  Adam W. Bero,et al.  Disruption of the Sleep-Wake Cycle and Diurnal Fluctuation of β-Amyloid in Mice with Alzheimer’s Disease Pathology , 2012, Science Translational Medicine.

[74]  F. Peña-Ortega,et al.  Amyloid beta 1-42 inhibits entorhinal cortex activity in the beta-gamma range: role of GSK-3. , 2012, Current Alzheimer research.

[75]  Nick C Fox,et al.  Clinical and biomarker changes in dominantly inherited Alzheimer's disease. , 2012, The New England journal of medicine.

[76]  Keith A. Vossel,et al.  Levetiracetam suppresses neuronal network dysfunction and reverses synaptic and cognitive deficits in an Alzheimer’s disease model , 2012, Proceedings of the National Academy of Sciences.

[77]  Michael Lagler,et al.  Behavior-dependent specialization of identified hippocampal interneurons , 2012, Nature Neuroscience.

[78]  M. Eguchi,et al.  Orchestrated experience-driven Arc/Arg3.1 responses are disrupted in a mouse model of Alzheimer’s disease , 2012, Nature Neuroscience.

[79]  D. Holtzman,et al.  Emergence of a seizure phenotype in aged apolipoprotein epsilon 4 targeted replacement mice , 2012, Brain Research.

[80]  Ole A. Andreassen,et al.  A mutation in APP protects against Alzheimer’s disease and age-related cognitive decline , 2012, Nature.

[81]  William A Catterall,et al.  Autistic behavior in Scn1a+/− mice and rescue by enhanced GABAergic transmission , 2012, Nature.

[82]  A. Vortmeyer,et al.  Alzheimer Amyloid-β Oligomer Bound to Post-Synaptic Prion Protein Activates Fyn to Impair Neurons , 2012, Nature Neuroscience.

[83]  E. Mandelkow,et al.  Biochemistry and cell biology of tau protein in neurofibrillary degeneration. , 2012, Cold Spring Harbor perspectives in medicine.

[84]  S. Tanimukai,et al.  Phenotypical difference of Amyloid Precursor Protein (APP) V717L mutation in Japanese family , 2012, BMC Neurology.

[85]  Bert Sakmann,et al.  Critical role of soluble amyloid-β for early hippocampal hyperactivity in a mouse model of Alzheimer’s disease , 2012, Proceedings of the National Academy of Sciences.

[86]  Amy L. Shelton,et al.  Reduction of Hippocampal Hyperactivity Improves Cognition in Amnestic Mild Cognitive Impairment , 2012, Neuron.

[87]  Edward O. Mann,et al.  Inhibitory Interneuron Deficit Links Altered Network Activity and Cognitive Dysfunction in Alzheimer Model , 2012, Cell.

[88]  Frances S. Chance,et al.  Erratum: Orthogonal micro-organization of orientation and spatial frequency in primate primary visual cortex , 2013, Nature Neuroscience.

[89]  Donald A. Wilson,et al.  ApoE-Directed Therapeutics Rapidly Clear β-Amyloid and Reverse Deficits in AD Mouse Models , 2012, Science.

[90]  L. Mucke,et al.  Alzheimer Mechanisms and Therapeutic Strategies , 2012, Cell.

[91]  P. Tariot,et al.  Incidence of new-onset seizures in mild to moderate Alzheimer disease. , 2012, Archives of neurology.

[92]  J. Hardy,et al.  Duplication of amyloid precursor protein (APP), but not prion protein (PRNP) gene is a significant cause of early onset dementia in a large UK series , 2012, Neurobiology of Aging.

[93]  B. Strooper,et al.  The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes , 2012, Nature Neuroscience.

[94]  J. Poulet,et al.  Thalamic control of cortical states , 2012, Nature Neuroscience.

[95]  R. Schmidt,et al.  Cross-Frequency Phase–Phase Coupling between Theta and Gamma Oscillations in the Hippocampus , 2012, The Journal of Neuroscience.

[96]  Daniel N. Hill,et al.  Staged decline of neuronal function in vivo in an animal model of Alzheimer's disease , 2012, Nature Communications.

[97]  Kelly O'Keefe,et al.  Hippocampal Hyperactivation Associated with Cortical Thinning in Alzheimer's Disease Signature Regions in Non-Demented Elderly Adults , 2011, The Journal of Neuroscience.

[98]  Juan R. Vidal,et al.  Transient Suppression of Broadband Gamma Power in the Default-Mode Network Is Correlated with Task Complexity and Subject Performance , 2011, The Journal of Neuroscience.

[99]  B. Strooper,et al.  The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics , 2011, Nature Reviews Drug Discovery.

[100]  K. Harris,et al.  Cortical state and attention , 2011, Nature Reviews Neuroscience.

[101]  H. Mori,et al.  Clinical Course of Patients with Familial Early-Onset Alzheimer’s Disease Potentially Lacking Senile Plaques Bearing the E693Δ Mutation in Amyloid Precursor Protein , 2011, Dementia and Geriatric Cognitive Disorders.

[102]  S. Rothman,et al.  A new mechanism for antiepileptic drug action: vesicular entry may mediate the effects of levetiracetam. , 2011, Journal of neurophysiology.

[103]  Meaghan Morris,et al.  The Many Faces of Tau , 2011, Neuron.

[104]  K. Nabeshima,et al.  The developmental changes of Nav1.1 and Nav1.2 expression in the human hippocampus and temporal lobe , 2011, Brain Research.

[105]  Shaomin Li,et al.  Soluble Aβ Oligomers Inhibit Long-Term Potentiation through a Mechanism Involving Excessive Activation of Extrasynaptic NR2B-Containing NMDA Receptors , 2011, The Journal of Neuroscience.

[106]  A. Larner.  Presenilin-1 mutation Alzheimer's disease: A genetic epilepsy syndrome? , 2011, Epilepsy & Behavior.

[107]  Nick C Fox,et al.  The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.

[108]  J. Morris,et al.  The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.

[109]  Jee Hoon Roh,et al.  Neuronal activity regulates the regional vulnerability to amyloid-β deposition , 2011, Nature Neuroscience.

[110]  W. J. Riedel,et al.  40-Hz steady state response in Alzheimer's disease and mild cognitive impairment , 2011, Neurobiology of Aging.

[111]  L. Mucke,et al.  Amyloid-β/Fyn–Induced Synaptic, Network, and Cognitive Impairments Depend on Tau Levels in Multiple Mouse Models of Alzheimer's Disease , 2011, The Journal of Neuroscience.

[112]  Jeffrey Noebels,et al.  A perfect storm: Converging paths of epilepsy and Alzheimer’s dementia intersect in the hippocampal formation , 2011, Epilepsia.

[113]  Francisco Lopera,et al.  Hippocampal hyperactivation in presymptomatic familial Alzheimer's disease , 2010, Annals of neurology.

[114]  Julie A. Harris,et al.  Transsynaptic Progression of Amyloid-β-Induced Neuronal Dysfunction within the Entorhinal-Hippocampal Network , 2010, Neuron.

[115]  Yadong Huang,et al.  Apolipoprotein E4 Causes Age- and Tau-Dependent Impairment of GABAergic Interneurons, Leading to Learning and Memory Deficits in Mice , 2010, The Journal of Neuroscience.

[116]  Kai Zhang,et al.  Tau Reduction Prevents Aβ-Induced Defects in Axonal Transport , 2010, Science.

[117]  P. Dutar,et al.  Decreased Rhythmic GABAergic Septal Activity and Memory-Associated θ Oscillations after Hippocampal Amyloid-β Pathology in the Rat , 2010, The Journal of Neuroscience.

[118]  Jürgen Götz,et al.  Dendritic Function of Tau Mediates Amyloid-β Toxicity in Alzheimer's Disease Mouse Models , 2010, Cell.

[119]  I. Vertkin,et al.  Basal GABA Regulates GABABR Conformation and Release Probability at Single Hippocampal Synapses , 2010, Neuron.

[120]  L. Mucke,et al.  Amyloid-β–induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks , 2010, Nature Neuroscience.

[121]  K. Zahs,et al.  Probing the Biology of Alzheimer's Disease in Mice , 2010, Neuron.

[122]  Rie Teraoka,et al.  A Mouse Model of Amyloid β Oligomers: Their Contribution to Synaptic Alteration, Abnormal Tau Phosphorylation, Glial Activation, and Neuronal Loss In Vivo , 2010, The Journal of Neuroscience.

[123]  O. Marín,et al.  Control of cortical GABA circuitry development by Nrg1 and ErbB4 signalling , 2010, Nature.

[124]  James B Leverenz,et al.  Alzheimer's disease phenotypes and genotypes associated with mutations in presenilin 2. , 2010, Brain : a journal of neurology.

[125]  L. Mucke,et al.  Synaptic Depression and Aberrant Excitatory Network Activity in Alzheimer’s Disease: Two Faces of the Same Coin? , 2010, NeuroMolecular Medicine.

[126]  Keith A. Johnson,et al.  Functional Alterations in Memory Networks in Early Alzheimer’s Disease , 2010, NeuroMolecular Medicine.

[127]  Adriano B. L. Tort,et al.  Theta–gamma coupling increases during the learning of item–context associations , 2009, Proceedings of the National Academy of Sciences.

[128]  Carol Brayne,et al.  Age, neuropathology, and dementia. , 2009, The New England journal of medicine.

[129]  I. Slutsky,et al.  Amyloid-β as a positive endogenous regulator of release probability at hippocampal synapses , 2009, Nature Neuroscience.

[130]  Seiji Nishino,et al.  Amyloid-β Dynamics Are Regulated by Orexin and the Sleep-Wake Cycle , 2009, Science.

[131]  Hyunmi Choi,et al.  Seizures in Alzheimer disease: who, when, and how common? , 2009, Archives of neurology.

[132]  D. Holtzman,et al.  The Role of Apolipoprotein E in Alzheimer's Disease , 2009, Neuron.

[133]  Keith A. Johnson,et al.  Amyloid Deposition Is Associated with Impaired Default Network Function in Older Persons without Dementia , 2009, Neuron.

[134]  N. Filippini,et al.  Distinct patterns of brain activity in young carriers of the APOE e4 allele , 2009, NeuroImage.

[135]  D. Bredesen.  Neurodegeneration in Alzheimer's disease: caspases and synaptic element interdependence , 2009, Molecular Neurodegeneration.

[136]  Shaomin Li,et al.  Soluble Oligomers of Amyloid β Protein Facilitate Hippocampal Long-Term Depression by Disrupting Neuronal Glutamate Uptake , 2009, Neuron.

[137]  Jessica A. Cardin,et al.  Driving fast-spiking cells induces gamma rhythm and controls sensory responses , 2009, Nature.

[138]  K. Deisseroth,et al.  Parvalbumin neurons and gamma rhythms enhance cortical circuit performance , 2009, Nature.

[139]  L. Mucke,et al.  Epilepsy and cognitive impairments in Alzheimer disease. , 2009, Archives of neurology.

[140]  W. Singer,et al.  Neural Synchrony in Cortical Networks: History, Concept and Current Status , 2009, Front. Integr. Neurosci..

[141]  Sylvain Rheims,et al.  Amyloid β-Induced Neuronal Hyperexcitability Triggers Progressive Epilepsy , 2009, The Journal of Neuroscience.

[142]  Kristina D. Micheva,et al.  Oligomeric amyloid β associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques , 2009, Proceedings of the National Academy of Sciences.

[143]  L. Mucke,et al.  Neprilysin Overexpression Inhibits Plaque Formation But Fails to Reduce Pathogenic Aβ Oligomers and Associated Cognitive Deficits in Human Amyloid Precursor Protein Transgenic Mice , 2009, The Journal of Neuroscience.

[144]  Robert Oostenveld,et al.  Trial-by-trial coupling between EEG and BOLD identifies networks related to alpha and theta EEG power increases during working memory maintenance , 2009, NeuroImage.

[145]  L. Mucke,et al.  Collagen VI protects neurons against Aβ toxicity , 2009, Nature Neuroscience.

[146]  A. Palmeri,et al.  Picomolar Amyloid-β Positively Modulates Synaptic Plasticity and Memory in Hippocampus , 2008, The Journal of Neuroscience.

[147]  Sean M Montgomery,et al.  Entrainment of Neocortical Neurons and Gamma Oscillations by the Hippocampal Theta Rhythm , 2008, Neuron.

[148]  L. Mucke,et al.  Phospholipase A2 reduction ameliorates cognitive deficits in a mouse model of Alzheimer's disease , 2008, Nature Neuroscience.

[149]  Arthur Konnerth,et al.  Clusters of Hyperactive Neurons Near Amyloid Plaques in a Mouse Model of Alzheimer's Disease , 2008, Science.

[150]  D. Selkoe,et al.  Soluble oligomers of the amyloid β-protein impair synaptic plasticity and behavior , 2008, Behavioural Brain Research.

[151]  J. Poulet,et al.  Internal brain state regulates membrane potential synchrony in barrel cortex of behaving mice , 2008, Nature.

[152]  Shaomin Li,et al.  Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory , 2008, Nature Medicine.

[153]  E. I. Rogaev,et al.  EEG alterations in non-demented individuals related to apolipoprotein E genotype and to risk of Alzheimer disease , 2008, Neurobiology of Aging.

[154]  Diana B Petitti,et al.  Social network, cognitive function, and dementia incidence among elderly women. , 2008, American journal of public health.

[155]  G. Waldemar,et al.  Atypical early-onset Alzheimer's disease caused by the Iranian APP mutation , 2008, Journal of Neurological Sciences.

[156]  L. Mucke,et al.  Enkephalin Elevations Contribute to Neuronal and Behavioral Impairments in a Transgenic Mouse Model of Alzheimer's Disease , 2008, The Journal of Neuroscience.

[157]  Sterling C. Johnson,et al.  fMRI activation during episodic encoding and metacognitive appraisal across the lifespan: Risk factors for Alzheimer's disease , 2008, Neuropsychologia.

[158]  L. Nyberg,et al.  Altered deactivation in individuals with genetic risk for Alzheimer's disease , 2008, Neuropsychologia.

[159]  G. Karmos,et al.  Entrainment of Neuronal Oscillations as a Mechanism of Attentional Selection , 2008, Science.

[160]  Brian Litt,et al.  Gamma Oscillations Distinguish True From False Memories , 2007, Psychological science.

[161]  Paul Maruff,et al.  β-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease , 2007 .

[162]  S. Rothman,et al.  Prolonged Exposure to Levetiracetam Reveals a Presynaptic Effect on Neurotransmission , 2007, Epilepsia.

[163]  Anatol C. Kreitzer,et al.  Aberrant Excitatory Neuronal Activity and Compensatory Remodeling of Inhibitory Hippocampal Circuits in Mouse Models of Alzheimer's Disease , 2007, Neuron.

[164]  Fiona E. N. LeBeau,et al.  Impairment of hippocampal gamma (γ)‐frequency oscillations in vitro in mice overexpressing human amyloid precursor protein (APP) , 2007, The European journal of neuroscience.

[165]  L. Mucke,et al.  Accelerating Amyloid-β Fibrillization Reduces Oligomer Levels and Functional Deficits in Alzheimer Disease Mouse Models* , 2007, Journal of Biological Chemistry.

[166]  Pablo Fuentealba,et al.  Cell Type-Specific Tuning of Hippocampal Interneuron Firing during Gamma Oscillations In Vivo , 2007, The Journal of Neuroscience.

[167]  J. Kaiser,et al.  Human gamma-frequency oscillations associated with attention and memory , 2007, Trends in Neurosciences.

[168]  O. Jensen,et al.  Cross-frequency coupling between neuronal oscillations , 2007, Trends in Cognitive Sciences.

[169]  V. Lee,et al.  BACE1 regulates voltage-gated sodium channels and neuronal activity , 2007, Nature Cell Biology.

[170]  D. Selkoe,et al.  Aβ Oligomers – a decade of discovery , 2007, Journal of neurochemistry.

[171]  L. Mucke,et al.  Reducing Endogenous Tau Ameliorates Amyloid ß-Induced Deficits in an Alzheimer's Disease Mouse Model , 2007, Science.

[172]  D. Campion,et al.  APP locus duplication in a Finnish family with dementia and intracerebral haemorrhage , 2007, Journal of Neurology, Neurosurgery, and Psychiatry.

[173]  Bernardo L Sabatini,et al.  Natural Oligomers of the Alzheimer Amyloid-β Protein Induce Reversible Synapse Loss by Modulating an NMDA-Type Glutamate Receptor-Dependent Signaling Pathway , 2007, The Journal of Neuroscience.

[174]  L. Mucke,et al.  Reelin Depletion in the Entorhinal Cortex of Human Amyloid Precursor Protein Transgenic Mice and Humans with Alzheimer's Disease , 2007, The Journal of Neuroscience.

[175]  B. Strooper.  Loss-of-function presenilin mutations in Alzheimer disease. Talking Point on the role of presenilin mutations in Alzheimer disease. , 2007 .

[176]  R. Malinow,et al.  AMPAR Removal Underlies Aβ-Induced Synaptic Depression and Dendritic Spine Loss , 2006, Neuron.

[177]  Peter Boesiger,et al.  Enhanced brain activity may precede the diagnosis of Alzheimer's disease by 30 years. , 2006, Brain : a journal of neurology.

[178]  Florence Pasquier,et al.  Phenotype associated with APP duplication in five families. , 2006, Brain : a journal of neurology.

[179]  K. Sleegers,et al.  APP duplication is sufficient to cause early onset Alzheimer's dementia with cerebral amyloid angiopathy. , 2006, Brain : a journal of neurology.

[180]  Vince D. Calhoun,et al.  Alterations in Memory Networks in Mild Cognitive Impairment and Alzheimer's Disease: An Independent Component Analysis , 2006, The Journal of Neuroscience.

[181]  M. Berger,et al.  High Gamma Power Is Phase-Locked to Theta Oscillations in Human Neocortex , 2006, Science.

[182]  D. C. Mccarthy,et al.  Hippocampal and neocortical gamma oscillations predict memory formation in humans. , 2006, Cerebral cortex.

[183]  Yaakov Stern,et al.  Incidence and Predictors of Seizures in Patients with Alzheimer's Disease , 2006, Epilepsia.

[184]  M. Gallagher,et al.  A specific amyloid-β protein assembly in the brain impairs memory , 2006, Nature.

[185]  M. Doran,et al.  Clinical phenotypic heterogeneity of Alzheimer's disease associated with mutations of the presenilin–1 gene , 2006, Journal of Neurology.

[186]  Steven Mennerick,et al.  Synaptic Activity Regulates Interstitial Fluid Amyloid-β Levels In Vivo , 2005, Neuron.

[187]  J. Morris,et al.  Novel presenilin 1 mutation (S170F) causing Alzheimer disease with Lewy bodies in the third decade of life. , 2005, Archives of neurology.

[188]  T. Demiralp,et al.  Human EEG gamma oscillations in neuropsychiatric disorders , 2005, Clinical Neurophysiology.

[189]  L. Mucke,et al.  Fyn Kinase Induces Synaptic and Cognitive Impairments in a Transgenic Mouse Model of Alzheimer's Disease , 2005, The Journal of Neuroscience.

[190]  Bertrand Z. Yeung,et al.  Vulnerability of Dentate Granule Cells to Disruption of Arc Expression in Human Amyloid Precursor Protein Transgenic Mice , 2005, The Journal of Neuroscience.

[191]  Benjamin J. Shannon,et al.  Molecular, Structural, and Functional Characterization of Alzheimer's Disease: Evidence for a Relationship between Default Activity, Amyloid, and Memory , 2005, The Journal of Neuroscience.

[192]  M. Albert,et al.  Increased hippocampal activation in mild cognitive impairment compared to normal aging and AD , 2005, Neurology.

[193]  W. Singer,et al.  Hemodynamic Signals Correlate Tightly with Synchronized Gamma Oscillations , 2005, Science.

[194]  S. Hestrin,et al.  Electrical synapses define networks of neocortical GABAergic neurons , 2005, Trends in Neurosciences.

[195]  Steven G Potkin,et al.  A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease , 2005, Nature Medicine.

[196]  Catherine Tallon-Baudry,et al.  The many faces of the gamma band response to complex visual stimuli , 2005, NeuroImage.

[197]  M. Staufenbiel,et al.  Neurobehavioral characterization of APP23 transgenic mice with the SHIRPA primary screen , 2005, Behavioural Brain Research.

[198]  J. Hardy,et al.  An African American family with early-onset Alzheimer disease and an APP (T714I) mutation , 2005, Neurology.

[199]  S. Finnilä,et al.  Hereditary dementia with intracerebral hemorrhages and cerebral amyloid angiopathy , 2004, Neurology.

[200]  M. Albert,et al.  Medial temporal lobe function and structure in mild cognitive impairment , 2004, Annals of neurology.

[201]  G. Buzsáki,et al.  Neuronal Oscillations in Cortical Networks , 2004, Science.

[202]  M. Sheng,et al.  Role of NMDA Receptor Subtypes in Governing the Direction of Hippocampal Synaptic Plasticity , 2004, Science.

[203]  M. Albert,et al.  Early Aβ accumulation and progressive synaptic loss, gliosis, and tangle formation in AD brain , 2004, Neurology.

[204]  Joanna L. Jankowsky,et al.  Mutant presenilins specifically elevate the levels of the 42 residue β-amyloid peptide in vivo: evidence for augmentation of a 42-specific γ secretase , 2004 .

[205]  Tamás F Freund,et al.  Interneuron Diversity series: Rhythm and mood in perisomatic inhibition , 2003, Trends in Neurosciences.

[206]  Andreas Kleinschmidt,et al.  EEG-correlated fMRI of human alpha activity , 2003, NeuroImage.

[207]  Jacob Raber,et al.  Neuronal depletion of calcium-dependent proteins in the dentate gyrus is tightly linked to Alzheimer's disease-related cognitive deficits , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[208]  T. Saido,et al.  Dutch, Flemish, Italian, and Arctic mutations of APP and resistance of Aβ to physiologically relevant proteolytic degradation , 2003, The Lancet.

[209]  R. Malinow,et al.  APP Processing and Synaptic Function , 2003, Neuron.

[210]  P. Somogyi,et al.  Brain-state- and cell-type-specific firing of hippocampal interneurons in vivo , 2003, Nature.

[211]  Vinod Menon,et al.  Functional connectivity in the resting brain: A network analysis of the default mode hypothesis , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[212]  Mark S. Cohen,et al.  Simultaneous EEG and fMRI of the alpha rhythm , 2002, Neuroreport.

[213]  B. Ghetti,et al.  Presenilin-1 mutations of leucine 166 equally affect the generation of the Notch and APP intracellular domains independent of their effect on Aβ42 production , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[214]  W. K. Cullen,et al.  Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo , 2002, Nature.

[215]  S. Younkin,et al.  The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Aβ protofibril formation , 2001, Nature Neuroscience.

[216]  N. Logothetis,et al.  Neurophysiological investigation of the basis of the fMRI signal , 2001, Nature.

[217]  D. Mann,et al.  Amyloid angiopathy and variability in amyloid beta deposition is determined by mutation position in presenilin-1-linked Alzheimer's disease. , 2001, The American journal of pathology.

[218]  C. Finch,et al.  Targeting small Aβ oligomers: the solution to an Alzheimer's disease conundrum? , 2001, Trends in Neurosciences.

[219]  R. Anwyl,et al.  Use-Dependent Effects of Amyloidogenic Fragments of β-Amyloid Precursor Protein on Synaptic Plasticity in Rat Hippocampus In Vivo , 2001, The Journal of Neuroscience.

[220]  G L Shulman,et al.  INAUGURAL ARTICLE by a Recently Elected Academy Member:A default mode of brain function , 2001 .

[221]  C. Haass,et al.  Intramembrane proteolysis by presenilins , 2000, Nature Reviews Molecular Cell Biology.

[222]  Mark S. Cohen,et al.  Patterns of brain activation in people at risk for Alzheimer's disease. , 2000, The New England journal of medicine.

[223]  Kang Hu,et al.  High-Level Neuronal Expression of Aβ1–42 in Wild-Type Human Amyloid Protein Precursor Transgenic Mice: Synaptotoxicity without Plaque Formation , 2000, The Journal of Neuroscience.

[224]  B. Hyman,et al.  The impact of different presenilin 1 andpresenilin 2 mutations on amyloid deposition, neurofibrillary changes and neuronal loss in the familial Alzheimer's disease brain: evidence for other phenotype-modifying factors. , 1999, Brain : a journal of neurology.

[225]  D. Contreras,et al.  Spatiotemporal Analysis of Local Field Potentials and Unit Discharges in Cat Cerebral Cortex during Natural Wake and Sleep States , 1999, The Journal of Neuroscience.

[226]  R. Nicoll,et al.  Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[227]  R. Lesser,et al.  Functional mapping of human sensorimotor cortex with electrocorticographic spectral analysis. II. Event-related synchronization in the gamma band. , 1998, Brain : a journal of neurology.

[228]  L. Lannfelt,et al.  Wide range of disease onset in a family with Alzheimer disease and a His163Tyr mutation in the presenilin-1 gene. , 1998, Archives of Neurology.

[229]  J. Pernier,et al.  Stimulus Specificity of Phase-Locked and Non-Phase-Locked 40 Hz Visual Responses in Human , 1996, The Journal of Neuroscience.

[230]  W. Hauser,et al.  Dementia and adult-onset unprovoked seizures , 1996, Neurology.

[231]  D. Borchelt,et al.  Age-related CNS disorder and early death in transgenic FVB/N mice overexpressing Alzheimer amyloid precursor proteins , 1995, Neuron.

[232]  P. Gorelick,et al.  Early onset Alzheimer's disease in a South American pedigree from Argentina , 1995, Acta neurologica Scandinavica.

[233]  G. Buzsáki,et al.  Gamma (40-100 Hz) oscillation in the hippocampus of the behaving rat , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[234]  B. Winblad,et al.  A large Swedish family with Alzheimer's disease with a codon 670/671 amyloid precursor protein mutation. A clinical and genealogical investigation. , 1994, Archives of neurology.

[235]  Toru Shimizu,et al.  Clinical comparison of Alzheimer's disease in pedigrees with the codon 717 Val→Ile mutation in the amyloid precursor protein gene , 1993, Neurobiology of Aging.

[236]  J. Growdon,et al.  Release of amyloid beta-protein precursor derivatives by electrical depolarization of rat hippocampal slices. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[237]  R. Frackowiak,et al.  Familial Alzheimer's disease. A pedigree with a mis-sense mutation in the amyloid precursor protein gene (amyloid precursor protein 717 valine-->glycine). , 1993, Brain : a journal of neurology.

[238]  D. Salmon,et al.  Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment , 1991, Annals of neurology.

[239]  J. Morris,et al.  Advanced Alzheimer's disease is a risk factor for late-onset seizures. , 1990, Archives of neurology.

[240]  S. DeKosky,et al.  Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity , 1990, Annals of neurology.

[241]  R. S. Williams,et al.  A prospective study of Alzheimer disease in Down syndrome. , 1989, Archives of neurology.

[242]  W. Hauser,et al.  Seizures and myoclonus in patients with Alzheimer's disease , 1986, Neurology.

[243]  H H Jasper,et al.  CORTICAL EXCITATORY STATE AND VARIABILITY IN HUMAN BRAIN RHYTHMS. , 1936, Science.

[244]  B. Cretin,et al.  Epileptic Prodromal Alzheimer's Disease, a Retrospective Study of 13 New Cases: Expanding the Spectrum of Alzheimer's Disease to an Epileptic Variant? , 2016, Journal of Alzheimer's disease : JAD.

[245]  M. Raichle,et al.  Oxygen Level and LFP in Task-Positive and Task-Negative Areas: Bridging BOLD fMRI and Electrophysiology. , 2016, Cerebral cortex.

[246]  M. Brug,et al.  Molecular Mechanisms of Alzheimer’s Disease Protection by the A673T Allele of Amyloid Precursor Protein , 2014 .

[247]  F. Lopera,et al.  Phenotypic profile of early-onset familial Alzheimer's disease caused by presenilin-1 E280A mutation. , 2012, Journal of Alzheimer's disease : JAD.

[248]  M. Zöller,et al.  Supplementary Tables , 2010 .

[249]  T. Freund,et al.  Perisomatic Inhibition , 2007, Neuron.

[250]  Alexandra Flemming,et al.  Infectious disease: Unravelling SARS lethality , 2005, Nature Reviews Drug Discovery.

[251]  D. Selkoe,et al.  Natural oligomers of the amyloid-β protein specifically disrupt cognitive function , 2005, Nature Neuroscience.

[252]  T. Spires,et al.  Neuronal Structure is Altered by Amyloid Plaques , 2004, Reviews in the neurosciences.

[253]  L. Abbott,et al.  Synaptic computation , 2004, Nature.

[254]  P. Wong,et al.  Elevated β-secretase expression and enzymatic activity detected in sporadic Alzheimer disease , 2003, Nature Medicine.

[255]  L. Nee,et al.  Familial Alzheimer Disease: A Large, Multigeneration German Kindred , 1991, Alzheimer disease and associated disorders.

[256]  S. M. Sumi,et al.  Myoclonus, Seizures, and Paratonia in Alzheimer Disease , 1990, Alzheimer disease and associated disorders.

[257]  ALZHEIMER’S DISEASE AND RELATED DISORDERS- ORIGINAL ARTICLE Increased EEG gamma band activity in Alzheimer’s disease and mild cognitive impairment , 2022 .